By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The formation of the Kinomed Partnership was announced today to provide integrated services for protein kinase inhibitor discovery and development and other research.

The European partnership comprises Iota Pharmaceuticals, protein research firm KinaseDetect, and drug discovery firm SARomics Biostructures.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.